Strategic partnerships Venture Medical actively pursues partnerships with complementary wound care technologies such as Plasmacure and MIMOSA Diagnostics, signaling opportunities to cross-sell bundled solutions and co-market to clinicians and wound care providers.

Expansion in therapies Recent introduction of cold plasma therapy through a strategic partnership indicates a growth vector in advanced wound healing modalities, suggesting upsell potential to clinical customers seeking cutting-edge treatment options.

Clinical engagement Participation in SAWC Spring 2026 and ongoing clinician-facing outreach show a customer-facing sales motion with high touch engagement, ideal for field reps to build relationships and capture live feedback for product iterations.

Product portfolio Launch of MIMOSA Pro and the AmnioWrap2 partnership indicate a diversified, hands-on wound care offering, creating upsell opportunities across supply, devices, and diagnostics for practice-level procurement.

Growth signals Revenue range and mid-sized employee base position Venture Medical as a scalable but nimble partner, suitable for enterprise-style partnerships with distributors or hospital systems seeking value-driven wound care solutions.